Yuhui Pan
Overview
Explore the profile of Yuhui Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Z, Li Y, Liu Q, Chen X, Lin W, Wu W, et al.
Int Immunopharmacol
. 2025 Jan;
147():113944.
PMID: 39742726
Secreted phosphoprotein 1 (SPP1) shows carcinogenic potential in multiple cancers, yet its role in nasopharyngeal carcinoma (NPC) remains elusive. Leveraging transcriptomic data sourced from an NPC cohort at Fujian Cancer...
2.
Ding Q, Liu M, Pan Y, Wu Z, Wang J, Li Y, et al.
Front Immunol
. 2024 Nov;
15:1469435.
PMID: 39512352
Background: Recent studies have underscored the biological significance of RNA modifications in tumorigenicity and progression. However, the potential roles of RNA modifications in immune regulation and the formation of the...
3.
Pan Y, Zhang L, Xu S, Li Y, Huang Z, Li C, et al.
Sci Rep
. 2024 Nov;
14(1):26406.
PMID: 39488563
This study aimed to develop and validate a nomogram using clinical variables to guide personalized treatment strategies for adenoid cystic carcinoma of the head and neck (ACCHN). Data from 1069...
4.
Weng Y, Cai S, Li C, Xu Y, Pan Y, Huang Z, et al.
Sci Rep
. 2024 Oct;
14(1):24484.
PMID: 39424840
This study aimed to explore the selection of induction chemotherapy (IC) cycles for stage N3 nasopharyngeal carcinoma (NPC). We employed propensity score matching (PSM) to categorize patients into 3-cycle and...
5.
Li Y, Huang Z, Zeng X, Pan Y, Wu L, Wang J, et al.
Head Face Med
. 2024 Sep;
20(1):55.
PMID: 39342276
Purpose: The duration of response to treatment is a significant prognostic indicator, with early recurrence (ER) often predicting poorer survival outcomes in nasopharyngeal carcinoma (NPC) survivors. This study seeks to...
6.
Pan Y, Chen Z, Hong W, Huang Z, Li Y, Cai S, et al.
BMC Cancer
. 2024 May;
24(1):578.
PMID: 38734620
Objective: This study aims to develop a nomogram integrating inflammation (NLR), Prognostic Nutritional Index (PNI), and EBV DNA (tumor burden) to achieve personalized treatment and prediction for stage IVA NPC....
7.
Comorbidity profiling identifies potential subtype of elderly patients with nasopharyngeal carcinoma
Li Y, Pan Y, Huang Z, Wu L, Wu W, Xu S, et al.
Oncologist
. 2024 Apr;
29(8):e1020-e1030.
PMID: 38625619
Background: Few studies have assessed the comprehensive associations among comorbid diseases in elderly patients with nasopharyngeal carcinoma (NPC). This study sought to identify potential comorbidity patterns and explore the relationship...
8.
Bian Y, Pan Y, Zheng J, Zheng W, Qin L, Zhou G, et al.
Crit Care Med
. 2024 Mar;
52(6):e268-e278.
PMID: 38441040
Objective: Comparing the effects of extracorporeal cardiopulmonary resuscitation (ECPR) and conventional cardiopulmonary resuscitation (CCPR) on outcomes in patients with in-hospital cardiac arrest (IHCA) in China. The benefits of ECPR over...
9.
Han Y, Huang C, Pan Y, Gu X
J Alzheimers Dis
. 2024 Jan;
97(3):1033-1050.
PMID: 38217599
Alzheimer's disease (AD) involves degeneration of cells in the brain. Due to insidious onset and slow progression, AD is often not diagnosed until it gets progressed to a more severe...
10.
Jiang L, Bian Y, Liu W, Zheng W, Zheng J, Li C, et al.
Shock
. 2023 Nov;
61(2):204-208.
PMID: 38010311
Aims: Targeted temperature management is recommended for at least 24 h in comatose survivors of in-hospital cardiac arrest (IHCA) after the return of spontaneous circulation; however, whether an extension for...